| Kenneth Russell Manning, MD | |
|
1638 Owen Dr, Fayetteville, NC 28304-3424 | |
| (910) 609-6910 | |
| (910) 609-5219 |
| Full Name | Kenneth Russell Manning |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 37 Years |
| Location | 1638 Owen Dr, Fayetteville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003870171 | NPI | - | NPPES |
| 891297E | Medicaid | NC | |
| 1297E | Other | NC | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RX0202X | Internal Medicine - Medical Oncology | 32779 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cape Fear Valley Medical Center | Fayetteville, NC | Hospital |
| Cape Fear Valley Hoke Hospital | Raeford, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cumberland County Hospital System Inc | 1850204041 | 455 |
News Archive
Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease, suggests a genetics expert from the Perelman School of Medicine at the University of Pennsylvania in a Perspective article in the new issue of Science Translational Medicine.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes. The research team, led by scientists at the Johns Hopkins University School of Medicine, found that greater amounts of fatty acids used by the heart during stressful conditions like exercise can counteract the detrimental effects of excess glucose and improve the diabetic heart's pumping ability in several ways.
ERT, a leading provider of centralized services to the biopharmaceutical, medical device and related industries, today announced its new ERT Knowledge Series of educational papers, written by ERT experts. Each paper discusses issues relevant to patient safety in clinical trials today and further establishes ERT as an experienced and reliable partner in products and services for the clinical trials industry.
› Verified 7 days ago
| Entity Name | Cumberland County Hospital System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881946242 PECOS PAC ID: 1850204041 Enrollment ID: O20031112000693 |
News Archive
Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease, suggests a genetics expert from the Perelman School of Medicine at the University of Pennsylvania in a Perspective article in the new issue of Science Translational Medicine.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes. The research team, led by scientists at the Johns Hopkins University School of Medicine, found that greater amounts of fatty acids used by the heart during stressful conditions like exercise can counteract the detrimental effects of excess glucose and improve the diabetic heart's pumping ability in several ways.
ERT, a leading provider of centralized services to the biopharmaceutical, medical device and related industries, today announced its new ERT Knowledge Series of educational papers, written by ERT experts. Each paper discusses issues relevant to patient safety in clinical trials today and further establishes ERT as an experienced and reliable partner in products and services for the clinical trials industry.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth Russell Manning, MD Po Box 42935, Fayetteville, NC 28309-2935 Ph: (910) 609-6910 | Kenneth Russell Manning, MD 1638 Owen Dr, Fayetteville, NC 28304-3424 Ph: (910) 609-6910 |
News Archive
Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease, suggests a genetics expert from the Perelman School of Medicine at the University of Pennsylvania in a Perspective article in the new issue of Science Translational Medicine.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes. The research team, led by scientists at the Johns Hopkins University School of Medicine, found that greater amounts of fatty acids used by the heart during stressful conditions like exercise can counteract the detrimental effects of excess glucose and improve the diabetic heart's pumping ability in several ways.
ERT, a leading provider of centralized services to the biopharmaceutical, medical device and related industries, today announced its new ERT Knowledge Series of educational papers, written by ERT experts. Each paper discusses issues relevant to patient safety in clinical trials today and further establishes ERT as an experienced and reliable partner in products and services for the clinical trials industry.
› Verified 7 days ago
Kenneth Melton, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 557 Sandhurst Dr, Fayetteville, NC 28304 Phone: 910-484-8114 Fax: 910-484-1564 | |
San San Wai, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2300 Ramsey St, Va Medical Center, Fayetteville, NC 28301 Phone: 910-488-2120 | |
Dr. Sabena Johnson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Ramsey St, Fayetteville, NC 28301 Phone: 910-488-2120 | |
Dr. Stephen S Logue, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1843 Quiet Cv, Fayetteville, NC 28304 Phone: 910-483-8080 Fax: 910-483-3258 | |
David Tat, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Owen Dr, Fayetteville, NC 28304 Phone: 910-678-0100 Fax: 910-678-0110 | |
Dr. Ghanshyam Pradyumna Dwivedi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1778 Metromedical Dr, Fayetteville, NC 28304 Phone: 910-483-4680 Fax: 910-484-2704 |